Structure

InChI Key FJZZPCZKBUKGGU-AUSIDOKSSA-N
Smile CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2
InChI
InChI=1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/t19-,23-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H36N2O4
Molecular Weight 404.55
AlogP 3.43
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 11.0
Polar Surface Area 71.03
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 29.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Transferase
- 16 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Gaucher Disease 3 D005776 ClinicalTrials
Gaucher Disease 3 D005776 ClinicalTrials
Gaucher Disease 3 D005776 ClinicalTrials
Hematologic Neoplasms 1 D019337 ClinicalTrials

Related Entries

Salt

Cross References

Resources Reference
CAS NUMBER 491833-29-5
ChEBI 82752
ChEMBL CHEMBL2110588
DrugBank DB09039
DrugCentral 4834
FDA SRS DR40J4WA67
Guide to Pharmacology 7536
PharmGKB PA166123486
PubChem 23652731
SureChEMBL SCHEMBL421755
ZINC ZINC000072267023